Budesonide jet nebuliser inhalation - Adams/Therapeutics 2000
Alternative Names: S 1320 jet nebuliser inhalation - Adams/Therapeutics 2000Latest Information Update: 19 Dec 2021
Price :
$50 *
At a glance
- Originator Therapeutics 2000
- Developer Adams Respiratory Therapeutics; Therapeutics 2000
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antivirals; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 06 Jun 2001 No-Development-Reported for Asthma in USA (Inhalation)
- 06 Jun 2001 No-Development-Reported for Emphysema in USA (Inhalation)
- 02 Nov 1998 Investigation in Asthma in USA (Inhalation)